Faculty Opinions recommendation of 52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B.

2013 ◽  
Author(s):  
Philip Rosenthal
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Efficacy And Safety ◽  
Positive Chronic Hepatitis

Efficacy and safety of peginterferon alfa-2a in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B

2013 ◽  
Vol 18 (6) ◽  
pp. 765-773 ◽  
Author(s):  
Dong Jin Suh ◽  
Han Chu Lee ◽  
Kwan Soo Byun ◽  
Mong Cho ◽  
Young Oh Kweon ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Efficacy And Safety ◽  
Positive Chronic Hepatitis ◽  
Peginterferon Alfa

scholarly journals 52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B

PLoS ONE ◽  
2013 ◽  
Vol 8 (2) ◽  
pp. e54279 ◽  
Author(s):  
Teerha Piratvisuth ◽  
Piyawat Komolmit ◽  
Tawesak Tanwandee ◽  
Wattana Sukeepaisarnjaroen ◽  
Henry L. Y. Chan ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Efficacy And Safety ◽  
Positive Chronic Hepatitis

scholarly journals Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

Hepatology ◽  
2008 ◽  
Vol 48 (3) ◽  
pp. 750-758 ◽  
Author(s):  
Patrick Marcellin ◽  
Ting-Tsung Chang ◽  
Seng G. Lee Lim ◽  
William Sievert ◽  
Myron Tong ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Adefovir Dipivoxil ◽  
Efficacy And Safety ◽  
Hepatitis B E Antigen ◽  
Term Efficacy ◽  
Positive Chronic Hepatitis
Sign in / Sign up

Export Citation Format

Share Document